Associations between intestinal fatty-acid binding protein and clinical and metabolic characteristics of depression.

Abdominal obesity Antidepressants Anxiety Depressive disorders Intestinal fatty acid-binding protein Intestinal permeability Leaky gut syndrome

Journal

Progress in neuro-psychopharmacology & biological psychiatry
ISSN: 1878-4216
Titre abrégé: Prog Neuropsychopharmacol Biol Psychiatry
Pays: England
ID NLM: 8211617

Informations de publication

Date de publication:
09 Oct 2024
Historique:
received: 20 02 2024
revised: 07 10 2024
accepted: 08 10 2024
medline: 12 10 2024
pubmed: 12 10 2024
entrez: 11 10 2024
Statut: aheadofprint

Résumé

The topic of increased intestinal permeability is associated with disruption of the intestinal barrier, leading to the "leaky gut" syndrome. Depressive disorders often coexist with abdominal obesity, metabolic syndrome, or its components and complications. Intestinal permeability has been proven to relate to all of the above. In this cross-sectional study, we aimed to assess the "leaky gut" blood biomarker - intestinal fatty acid-binding protein (I-FABP) - in 114 adult patients diagnosed with depressive disorders depending on abdominal obesity comorbidity, depression, anxiety, and stress level, or antidepressant use. The corrected p-value was set at 0.02. We analyzed patients' mental state, diet, anthropometric parameters, metabolic laboratory markers and I-FABP. There was no difference in circulating I-FABP levels between obese and non-obese patients with depressive disorders (p = 0.648). Similarly, I-FABP levels were not different in patients with different emotional symptoms severity (p = 0.829 for self-assessed depression, p = 0.164 for anxiety, and p = 0.543 for stress). But, I-FABP levels differed significantly between patients treated and not treated with antidepressants (p = 0.011). In general linear model analysis treatment with antidepressants, anxiety severity level, their interaction, along with smoking status, drinks intake, and using dietary supplements were shown to significantly explain I-FABP variance (p < 0.001, R Comorbid obesity did not increase intestinal permeability circulating marker, I-FABP, in the population of patients with depressive disorders. Treatment with antidepressants may be connected to higher I-FABP levels. Using dietary supplements, drinks intake, smoking status, or anxiety level may serve as explanatory factors.

Identifiants

pubmed: 39393435
pii: S0278-5846(24)00238-0
doi: 10.1016/j.pnpbp.2024.111170
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111170

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no competing interests to declare.

Auteurs

Oliwia Gawlik-Kotelnicka (O)

Department of Affective and Psychotic Disorders, Medical University of Lodz, Czechosłowacka 8/10, 92-216 Lodz, Poland. Electronic address: oliwia.gawlik@umed.lodz.pl.

Karolina Czarnecka-Chrebelska (K)

Department of Biomedicine and Genetics, Medical University of Lodz, 92-213 Lodz, Poland. Electronic address: karolina.czarnecka@umed.lodz.pl.

Aleksandra Margulska (A)

Department of Child and Adolescent Psychiatry, Medical University of Lodz, Czechosłowacka 8/10, 92-216 Lodz, Poland. Electronic address: aleksandra.margulska@umed.lodz.pl.

Ewa Pikus (E)

Department of Biomedicine and Genetics, Medical University of Lodz, 92-213 Lodz, Poland. Electronic address: ewa.pikus@umed.lodz.pl.

Jakub Wasiak (J)

Faculty of Medicine, Medical University of Lodz, Kościuszki 4, 90-419 Lodz, Poland. Electronic address: jakub.wasiak@stud.umed.lodz.pl.

Anna Skowrońska (A)

Department of Affective and Psychotic Disorders, Medical University of Lodz, Czechosłowacka 8/10, 92-216 Lodz, Poland.

Ewa Brzeziańska-Lasota (E)

Department of Biomedicine and Genetics, Medical University of Lodz, 92-213 Lodz, Poland. Electronic address: ewa.brzezianska@umed.lodz.pl.

Dominik Strzelecki (D)

Department of Affective and Psychotic Disorders, Medical University of Lodz, Czechosłowacka 8/10, 92-216 Lodz, Poland. Electronic address: dominik.strzelecki@umed.lodz.pl.

Classifications MeSH